Physician profile
John Delgado
NPI 1225204845
$2,346.47
in general payments reported to CMS, 2019-2025
12 companies · $499 in 2025
The $499 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.58 · 2020: $26.39 · 2021: $285 · 2022: $725 · 2023: $272 · 2024: $498 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.81 |
| Education | $113.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,568.17 | 2021-2025 | Mako, Gamma, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $330.98 | 2022-2025 | Tapestry, Gel-One Cross-Linked Hyaluronate, Avenir |
| Micromed INC | $147.51 | 2021 | |
| Depuy Synthes Sales INC. | $74.63 | 2019-2023 | Orthovisc, Monovisc |
| Bioventus LLC | $65.07 | 2024-2025 | Xcell, Supartz Fx Sodium Hyaluronate, Exogen Ultrasound Bone Healing System |
| Saxum Surgical, INC. | $47.62 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $33.18 | 2025 | |
| Innovation Technologies INC | $20.86 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.40 | 2019 | |
| Pacira Therapeutics, INC. | $15.39 | 2020 | |
| Medtronic, INC. | $13.66 | 2024 | Plasmablade(Tm) |
| Assertio Therapeutics, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Delgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.